LivaNova (LIVN) Other Non-Current Liabilities (2015 - 2026)
LivaNova (LIVN) posted Other Non-Current Liabilities of $54.4 million for Q1 2026, up 29.34% sequentially from $42.0 million in Q4 2025, and up 14.98% YoY from $47.3 million in Q1 2025.
LivaNova (LIVN) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
LivaNova has reported Other Non-Current Liabilities for 12 years, with the latest figure at $54.4 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 14.98% year-over-year to $54.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.4 million (up 14.98% YoY) and the FY2025 annual result came in at $42.0 million, down 5.47% from the prior year.
- Other Non-Current Liabilities advanced to $54.4 million in Q1 2026 per LIVN's latest filing, from $42.0 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $104.9 million in Q1 2024 and troughed at $39.7 million in Q2 2025.
- A 5-year average of $59.8 million and a median of $47.3 million in 2025 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities slumped 59.28% in 2022, then soared 126.76% in 2024.
- Over 5 years, Other Non-Current Liabilities stood at $85.3 million in 2022, then declined by 5.15% to $80.9 million in 2023, then sank by 45.02% to $44.5 million in 2024, then retreated by 5.47% to $42.0 million in 2025, then climbed by 29.34% to $54.4 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $54.4 million, $42.0 million, and $64.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn |
| 2 | Stryker | 127.82 Bn | 124.35 Bn | 4.50 Bn |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.38 Bn | 72.84 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn |
| 6 | Dexcom | 34.44 Bn | 32.50 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.80 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 152.90 Mn |
| Mar 31, 2026 | 54.38 Mn |
| Dec 31, 2025 | 42.05 Mn |
| Sep 30, 2025 | 64.52 Mn |
| Jun 30, 2025 | 39.66 Mn |
| Mar 31, 2025 | 47.29 Mn |
| Dec 31, 2024 | 44.48 Mn |
| Sep 30, 2024 | 47.04 Mn |
| Jun 30, 2024 | 81.17 Mn |
| Mar 31, 2024 | 104.92 Mn |
| Dec 31, 2023 | 80.90 Mn |
| Sep 30, 2023 | 46.26 Mn |
| Jun 30, 2023 | 92.63 Mn |
| Mar 31, 2023 | 46.27 Mn |
| Dec 31, 2022 | 85.29 Mn |
| Sep 30, 2022 | 42.39 Mn |
| Jun 30, 2022 | 47.19 Mn |
| Mar 31, 2022 | 49.77 Mn |
| Dec 31, 2021 | 86.83 Mn |
| Sep 30, 2021 | 104.08 Mn |